Morgan Stanley’s Citius Pharmaceuticals CTXR Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $95 | Hold |
60
| – | – | ﹤0.01% | 7657 |
|
|
2025
Q1 | $89 | Sell |
60
-258
| -81% | -$383 | ﹤0.01% | 7592 |
|
|
2024
Q4 | $1.27K | Sell |
318
-1,182
| -79% | -$4.73K | ﹤0.01% | 7244 |
|
|
2024
Q3 | $751 | Sell |
1,500
-8,240
| -85% | -$4.13K | ﹤0.01% | 7263 |
|
|
2024
Q2 | $5.69K | Sell |
9,740
-181,927
| -95% | -$106K | ﹤0.01% | 6819 |
|
|
2024
Q1 | $172K | Sell |
191,667
-296,251
| -61% | -$266K | ﹤0.01% | 5778 |
|
|
2023
Q4 | $369K | Buy |
487,918
+411,902
| +542% | +$312K | ﹤0.01% | 5734 |
|
|
2023
Q3 | $52K | Sell |
76,016
-28,005
| -27% | -$19.2K | ﹤0.01% | 6152 |
|
|
2023
Q2 | $125K | Sell |
104,021
-32,468
| -24% | -$39K | ﹤0.01% | 5847 |
|
|
2023
Q1 | $160K | Buy |
136,489
+25,115
| +23% | +$29.4K | ﹤0.01% | 5809 |
|
|
2022
Q4 | $88K | Sell |
111,374
-37,136
| -25% | -$29.3K | ﹤0.01% | 6037 |
|
|
2022
Q3 | $179K | Sell |
148,510
-59,241
| -29% | -$71.4K | ﹤0.01% | 5777 |
|
|
2022
Q2 | $191K | Buy |
207,751
+161,539
| +350% | +$149K | ﹤0.01% | 5923 |
|
|
2022
Q1 | $83K | Buy |
46,212
+5,738
| +14% | +$10.3K | ﹤0.01% | 6433 |
|
|
2021
Q4 | $61K | Buy |
40,474
+28,076
| +226% | +$42.3K | ﹤0.01% | 6715 |
|
|
2021
Q3 | $25K | Buy |
12,398
+3,653
| +42% | +$7.37K | ﹤0.01% | 7007 |
|
|
2021
Q2 | $30K | Sell |
8,745
-31,255
| -78% | -$107K | ﹤0.01% | 6855 |
|
|
2021
Q1 | $71K | Buy |
+40,000
| New | +$71K | ﹤0.01% | 6184 |
|
|
2019
Q2 | – | Sell |
-21,000
| Closed | -$29K | – | 6659 |
|
|
2019
Q1 | $29K | Buy |
+21,000
| New | +$29K | ﹤0.01% | 5887 |
|
|
2018
Q4 | – | Sell |
-40
| Closed | – | – | 6611 |
|
|
2018
Q3 | $0 | Buy |
40
+23
| +135% | – | ﹤0.01% | 6723 |
|
|
2018
Q2 | $0 | Buy |
+17
| New | – | ﹤0.01% | 6676 |
|
|
2017
Q4 | – | Sell |
-210
| Closed | -$1K | – | 6578 |
|
|
2017
Q3 | $1K | Buy |
+210
| New | +$1K | ﹤0.01% | 6436 |
|